Physician
Dublin Pain Clinic LLC
Dublin Pain Clinic LLC was paid $2.18M by Medicaid between Jan 2018 and Dec 2024, across 66 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 20% of everything it billed.
33Billing provider infoDUBLIN PAIN CLINIC LLC
COLUMBUS, OH 43228
COLUMBUS, OH 43228
33aNPI1013103019assigned 09/24/2007
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$2.18M
24GClaims100,628
24DCodes billed66
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Ohio
Rank by total paid#2 of 43
Median peer was paid$52K
This provider vs. median42×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,338 | $352K | |
| 2019 | 42,650 | $693K | |
| 2020 | 18,866 | $383K | |
| 2021 | 9,405 | $288K | |
| 2022 | 5,640 | $191K | |
| 2023 | 4,071 | $135K | |
| 2024incomplete | 3,658 | $138K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 14,571 | 11,591 | $431K |
| 27096 | 15% | 2,404 | 1,912 | $332K | |
| 64493 | 7.4% | 2,215 | 1,719 | $161K | |
| 64635 | 7.2% | 1,482 | 1,195 | $156K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 5.2% | 891 | 841 | $113K |
| 64636 | 4.4% | 1,412 | 1,132 | $97K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 3.6% | 1,033 | 964 | $78K |
| 64494 | 3.4% | 2,183 | 1,661 | $75K | |
| 64495 | 2.4% | 1,449 | 1,136 | $53K | |
| 64483 | 2.2% | 666 | 516 | $48K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 619 | 601 | $45K |
| 80305 | 2.0% | 5,261 | 4,893 | $43K |
54 more codes
| 64484 | 1.7% | 656 | $37K | |
| 80346 | 1.5% | 1,517 | $33K | |
| 80361 | 1.5% | 1,765 | $33K | |
| 80362 | 1.0% | 1,246 | $23K | |
| 83992 | <1% | 1,371 | $20K | |
| 80354 | <1% | 1,763 | $18K | |
| 80365 | <1% | 1,764 | $18K | |
| 80373 | <1% | 1,747 | $18K | |
| 80358 | <1% | 1,746 | $18K | |
| 80320 | <1% | 1,246 | $17K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 379 | $17K |
| 80324 | <1% | 1,512 | $16K | |
| 80349 | <1% | 1,519 | $16K | |
| 80353 | <1% | 1,517 | $16K | |
| 80356 | <1% | 1,516 | $16K | |
| 80368 | <1% | 1,494 | $15K | |
| 80360 | <1% | 1,494 | $15K | |
| 80323 | <1% | 1,387 | $14K | |
| 80350 | <1% | 1,328 | $14K | |
| 80367 | <1% | 1,307 | $13K | |
| 80337 | <1% | 1,246 | $13K | |
| 80345 | <1% | 1,246 | $13K | |
| 80348 | <1% | 1,246 | $13K | |
| 80355 | <1% | 1,204 | $12K | |
| 80369 | <1% | 1,201 | $12K | |
| 80366 | <1% | 1,177 | $12K | |
| 80372 | <1% | 1,172 | $12K | |
| 80333 | <1% | 1,073 | $11K | |
| 80371 | <1% | 1,073 | $11K | |
| 80364 | <1% | 512 | $10K | |
| 62323 | <1% | 69 | $7K | |
| 64633 | <1% | 59 | $7K | |
| 64634 | <1% | 57 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 80 | $3K |
| A4649 | Surgical supply; miscellaneous | <1% | 243 | $3K |
| 20610 | <1% | 92 | $3K | |
| 64490 | <1% | 43 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,348 | $2K |
| 64491 | <1% | 42 | $1K | |
| 80359 | <1% | 119 | $1K | |
| 80336 | <1% | 119 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 13 | $1K |
| 64492 | <1% | 42 | $1K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 13 | $992.36 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,343 | $980.71 |
| 77002 | <1% | 163 | $974.77 | |
| 77003 | <1% | 293 | $705.68 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,564 | $618.03 |
| J3490 | Unclassified drugs | <1% | 4,431 | $379.03 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,810 | $244.49 |
| A4209 | Syringe with needle, sterile 5 cc or greater, each | <1% | 2,072 | $153.03 |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 1,452 | $116.71 |
| A4215 | Needle, sterile, any size, each | <1% | 1,921 | $3.09 |
| A4550 | Surgical trays | <1% | 1,630 | $1.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIDDIQUI, SAUD (PHYSICIAN/OWNER)
| Provider | Location | Paid |
|---|---|---|
| Columbus Spine Specialists LLC | Columbus, OH | $582K |
| Sun Medical Laboratories INC | Lombard, IL | $507.32 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.